Biochemical Studies of Worm Insulins
蠕虫胰岛素的生化研究
基本信息
- 批准号:6802446
- 负责人:
- 金额:$ 27.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-20 至 2007-07-31
- 项目状态:已结题
- 来源:
- 关键词:Caenorhabditis elegansX ray crystallographyanalytical ultracentrifugationbinding proteinsbiochemistryhelminth geneticsinsulininsulin receptorinsulinlike growth factornuclear magnetic resonance spectroscopypeptide chemical synthesispolymerase chain reactionprotein structure functionprotein tyrosine kinasereceptor bindingrecombinant proteinssite directed mutagenesis
项目摘要
DESCRIPTION (provided by applicant):
An insulin-related signaling pathway in the nematode Caenorhabditis elegans controls aging and life span. Remarkably, the C. elegans genome contains 38 putative insulin-like genes and a single orthologue of the human insulin receptor (designated daf-2). Do nematode insulin-like proteins truly resemble mammalian insulins in structure and function? Why are there such a diversity of ligands? We propose to synthesize representative insulin-like polypeptides (INS proteins) and investigate their structures and receptor-binding properties. The proposed studies will illuminate the evolution of the insulin structure and dissect a signaling pathway in a genetic model of senescence.
The proposed studies focus on four questions. (1) Given their sequence divergence, are INS proteins truly members of the insulin superfamily, and if so, how are the divergent side chains accommodated within a conserved architecture? (2) Does DAF-2 function as a receptor tyrosine kinase, and if so, is its kinase activity positively or negatively regulated by INS ligands? (3) Do INS proteins bind to the human insulin receptor, and if so, how can their seemingly divergent surfaces mimic human insulin? (4) Conversely, does human insulin bind to and regulate DAF-2? A long-term collaboration is proposed with Prof. Guy G. Dodson to compare co-crystal structures of hormone-receptor complexes. Preliminary studies of a representative INS protein have established that -- despite an overall insulin-like fold -- its putative receptor-binding surface differs dramatically from that of human insulin. As a seeming paradox, the protein nonetheless binds to and activates the human insulin receptor. Human insulin likewise binds to the DAF-2 receptor. Novel INS ligands may provide an unexpected starting point for design of human insulin agonists. Given the growing importance of insulin analogs to optimize treatment of diabetes mellitus and the possible clinical utility of IGF-I antagonists in cancer therapy, studies of the INS family may have translational implications in therapeutic protein design.
描述(由申请人提供):
线虫中的胰岛素相关信号通路控制衰老和寿命。值得注意的是,C.线虫基因组含有38个推定的胰岛素样基因和人胰岛素受体的单一直向同源物(命名为DAF-2)。线虫胰岛素样蛋白在结构和功能上真的与哺乳动物胰岛素相似吗?为什么会有如此多样的配体?我们建议合成代表性的胰岛素样多肽(INS蛋白),并研究其结构和受体结合特性。拟议的研究将阐明胰岛素结构的演变,并剖析衰老遗传模型中的信号通路。
建议的研究集中在四个问题。(1)考虑到它们的序列差异,INS蛋白质真的是胰岛素超家族的成员吗?如果是的话,不同的侧链是如何容纳在一个保守的结构中的?(2)INS-2是否作为受体酪氨酸激酶发挥作用?如果是,其激酶活性是否受INS配体的正或负调节?(3)INS蛋白质与人胰岛素受体结合吗?如果是这样,它们看似不同的表面是如何模仿人胰岛素的?(4)相反,人胰岛素是否与β 2结合并调节β 2?建议与Guy G教授进行长期合作。Dodson比较了受体-受体复合物的共晶体结构。对代表性INS蛋白的初步研究已经确定,尽管总体上具有胰岛素样折叠,但其推定的受体结合表面与人胰岛素的受体结合表面显著不同。作为一个看似矛盾的,蛋白质仍然结合并激活人类胰岛素受体。人胰岛素同样与β 2受体结合。新型INS配体可能为设计人胰岛素激动剂提供意想不到的起点。鉴于胰岛素类似物对优化糖尿病治疗的重要性日益增加,以及IGF-I拮抗剂在癌症治疗中的可能临床用途,INS家族的研究可能在治疗性蛋白质设计中具有翻译意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL Aaron WEISS其他文献
MICHAEL Aaron WEISS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL Aaron WEISS', 18)}}的其他基金
相似海外基金
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - PROTEIN EXPRESSION AND/OR X-RAY CRYSTALLOGRAPHY
化学筛选和优化设施 - 蛋白质表达和/或 X 射线晶体学
- 批准号:
10942884 - 财政年份:2023
- 资助金额:
$ 27.37万 - 项目类别:
Taking Snapshots of Enzymatic Reactions Using X-ray Crystallography and Spectroscopy
使用 X 射线晶体学和光谱学拍摄酶反应快照
- 批准号:
10623717 - 财政年份:2023
- 资助金额:
$ 27.37万 - 项目类别:
EAGER: JOINT CRYO NEUTRON/X-RAY CRYSTALLOGRAPHY OF RNA AND RNA-PROTEIN INTERACTIONS
EAGER:RNA 和 RNA-蛋白质相互作用的联合冷冻中子/X 射线晶体学
- 批准号:
2224897 - 财政年份:2022
- 资助金额:
$ 27.37万 - 项目类别:
Standard Grant
Protein structure-based enhancement of enzyme performance for food and bioproduct applications using X-ray crystallography, protein modification and metabolic engineering methods
使用 X 射线晶体学、蛋白质修饰和代谢工程方法,基于蛋白质结构增强食品和生物产品应用中的酶性能
- 批准号:
RGPIN-2016-06209 - 财政年份:2021
- 资助金额:
$ 27.37万 - 项目类别:
Discovery Grants Program - Individual
Time-Resolved X-ray Crystallography of Dynamics in Cysteine-Dependent Enzymes
半胱氨酸依赖性酶动力学的时间分辨 X 射线晶体学
- 批准号:
10684770 - 财政年份:2020
- 资助金额:
$ 27.37万 - 项目类别:
Time-Resolved X-ray Crystallography of Dynamics in Cysteine-Dependent Enzymes
半胱氨酸依赖性酶动力学的时间分辨 X 射线晶体学
- 批准号:
10259757 - 财政年份:2020
- 资助金额:
$ 27.37万 - 项目类别:
Elucidating the Hidden Steps of Replicative DNA Synthesis by Time-Resolved X-ray Crystallography
通过时间分辨 X 射线晶体学阐明复制 DNA 合成的隐藏步骤
- 批准号:
2001434 - 财政年份:2020
- 资助金额:
$ 27.37万 - 项目类别:
Standard Grant
Time-Resolved X-ray Crystallography of Dynamics in Cysteine-Dependent Enzymes
半胱氨酸依赖性酶动力学的时间分辨 X 射线晶体学
- 批准号:
10099548 - 财政年份:2020
- 资助金额:
$ 27.37万 - 项目类别:
Optimizing protein expression for X-ray crystallography studies and medicinal chemistry
优化 X 射线晶体学研究和药物化学的蛋白质表达
- 批准号:
552236-2020 - 财政年份:2020
- 资助金额:
$ 27.37万 - 项目类别:
University Undergraduate Student Research Awards
Protein structure-based enhancement of enzyme performance for food and bioproduct applications using X-ray crystallography, protein modification and metabolic engineering methods
使用 X 射线晶体学、蛋白质修饰和代谢工程方法,基于蛋白质结构增强食品和生物产品应用中的酶性能
- 批准号:
RGPIN-2016-06209 - 财政年份:2020
- 资助金额:
$ 27.37万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




